133 related articles for article (PubMed ID: 20163937)
1. Effect of hypertriglyceridemia on the pharmacokinetics and blood-brain barrier penetration of clozapine and norclozapine following administration to rats.
Gershkovich P; Sivak O; Sharma A; Barr AM; Procyshyn R; Wasan KM
Eur Neuropsychopharmacol; 2010 Aug; 20(8):545-52. PubMed ID: 20163937
[TBL] [Abstract][Full Text] [Related]
2. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).
Flanagan RJ; Amin A; Seinen W
Forensic Sci Int; 2003 Mar; 132(1):9-17. PubMed ID: 12689746
[TBL] [Abstract][Full Text] [Related]
3. Microdialysis evaluation of clozapine and N-desmethylclozapine pharmacokinetics in rat brain.
Cremers TI; Flik G; Hofland C; Stratford RE
Drug Metab Dispos; 2012 Oct; 40(10):1909-16. PubMed ID: 22736307
[TBL] [Abstract][Full Text] [Related]
4. Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex).
Couchman L; Morgan PE; Spencer EP; Johnston A; Flanagan RJ
Ther Drug Monit; 2010 Oct; 32(5):624-7. PubMed ID: 20720516
[TBL] [Abstract][Full Text] [Related]
5. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
[TBL] [Abstract][Full Text] [Related]
6. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
[TBL] [Abstract][Full Text] [Related]
8. Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics.
Albitar O; Harun SN; Sheikh Ghadzi SM
CNS Drugs; 2024 Jul; 38(7):571-581. PubMed ID: 38836990
[TBL] [Abstract][Full Text] [Related]
9. Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics.
Li CH; Stratford RE; Velez de Mendizabal N; Cremers TI; Pollock BG; Mulsant BH; Remington G; Bies RR
J Transl Med; 2014 Aug; 12():203. PubMed ID: 25142323
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.
Consoli G; Lastella M; Ciapparelli A; Catena Dell'Osso M; Ciofi L; Guidotti E; Danesi R; Dell'Osso L; Del Tacca M; Di Paolo A
Pharmacogenomics; 2009 Aug; 10(8):1267-76. PubMed ID: 19663671
[TBL] [Abstract][Full Text] [Related]
11. Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia.
Ismail Z; Wessels AM; Uchida H; Ng W; Mamo DC; Rajji TK; Pollock BG; Mulsant BH; Bies RR
Am J Geriatr Psychiatry; 2012 Jan; 20(1):53-60. PubMed ID: 21422906
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics.
Raper J; Morrison RD; Daniels JS; Howell L; Bachevalier J; Wichmann T; Galvan A
ACS Chem Neurosci; 2017 Jul; 8(7):1570-1576. PubMed ID: 28324647
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.
Li LJ; Shang DW; Li WB; Guo W; Wang XP; Ren YP; Li AN; Fu PX; Ji SM; Lu W; Wang CY
Acta Pharmacol Sin; 2012 Nov; 33(11):1409-16. PubMed ID: 22820910
[TBL] [Abstract][Full Text] [Related]
14. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.
Couchman L; Morgan PE; Spencer EP; Flanagan RJ
Ther Drug Monit; 2010 Aug; 32(4):438-47. PubMed ID: 20463634
[TBL] [Abstract][Full Text] [Related]
15. Determination of clozapine and its metabolite, N-desmethylclozapine, in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats.
Ma F; Lau CE
J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):193-8. PubMed ID: 9698242
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic changes of clozapine and norclozapine in a rat model of non-alcoholic fatty liver disease induced by orotic acid.
Li Z; Lee SH; Jeong HJ; Kang HE
Xenobiotica; 2021 Mar; 51(3):324-334. PubMed ID: 33185134
[TBL] [Abstract][Full Text] [Related]
17. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
Hermida J; Paz E; Tutor JC
Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
[TBL] [Abstract][Full Text] [Related]
18. Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia.
Guitton C; Kinowski JM; Abbar M; Chabrand P; Bressolle F
J Clin Pharmacol; 1999 Jul; 39(7):721-8. PubMed ID: 10392327
[TBL] [Abstract][Full Text] [Related]
19. The Drug-Drug Effects of Rhein on the Pharmacokinetics and Pharmacodynamics of Clozapine in Rat Brain Extracellular Fluid by In Vivo Microdialysis.
Hou ML; Lin CH; Lin LC; Tsai TH
J Pharmacol Exp Ther; 2015 Oct; 355(1):125-34. PubMed ID: 26220937
[TBL] [Abstract][Full Text] [Related]
20. Suspected clozapine poisoning in the UK/Eire, 1992-2003.
Flanagan RJ; Spencer EP; Morgan PE; Barnes TR; Dunk L
Forensic Sci Int; 2005 Dec; 155(2-3):91-9. PubMed ID: 16226146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
